Andrew Feldmar: MDMA for PTSD

MDMA is evaluated as a therapeutic adjunct for individuals suffering from PTSD by psychotherapist Andrew Feldmar. This substance creates a unique state of consciousness characterized by a reduction in shame and the development of an open heart, which allows patients to overcome long standing emotional blockages. By facilitating meaningful human connection, MDMA effectively addresses the core impairment of PTSD, which is the inability to form such connections. Building upon the work of psychiatrist Judith Lewis Herman, Feldmar suggests that a broad range of mental distress syndromes could potentially be mitigated through efficient treatments for the aftereffects of trauma.